In this study, as an extension to our previous work on head and neck mucosal melanomas (31), we aimed to investigate the BRAF, NRAS, KIT, TERT and GNAQ/GNA11 mutation status of 15 AMs, as well as their clinicopathologic features. This evidence concerns the gene KIT and melanoma.